| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338055C Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 09/18/2007 | US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | CA2174133C Use of alpha receptor antagonists for the treatment of chronic muscle pain |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007101937A1 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament |
| 09/13/2007 | WO2007049089A8 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues |
| 09/13/2007 | WO2005115439A3 Cerberus/coco derivatives and uses thereof |
| 09/13/2007 | US20070212423 Stem cells that transform to beating cardiomyocytes |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/07/2007 | WO2007099151A1 Methods and agents for reducing oxidative stress |
| 09/07/2007 | WO2006079217A8 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 09/07/2007 | CA2644046A1 Metabolic regulators and uses thereof |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
| 09/05/2007 | EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 09/05/2007 | EP1828221A1 Pure rocuronium bromide |
| 09/05/2007 | EP1562570A4 Treatment of amyotrophic lateral sclerosis with nimesulide |
| 09/05/2007 | EP1441724B1 Methods of increasing endogenous testosterone levels |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | CN101031294A Use of alk 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals |
| 09/05/2007 | CN101029080A Methods and compositions for derepression of IAP-inhibited caspase |
| 09/05/2007 | CN101028472A Oral Chinese medicinal composition for treating lumbocostal overstrain |
| 09/05/2007 | CN101028366A Externally-applied Chinese medicinal composition for treating psoatic strain |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis |
| 09/04/2007 | US7265099 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 08/30/2007 | WO2007098106A2 Respiratory tract delivery of interferon-tau |
| 08/30/2007 | WO2007097289A1 Novel pharmaceutical |
| 08/30/2007 | WO2007097205A1 Eyedrops |
| 08/30/2007 | WO2007074477A3 Metaxalone polymorphs |
| 08/30/2007 | WO2007014278A3 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | US20070202197 PAWPAW and/or peach derived composition |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/29/2007 | EP1824488A1 Phycotoxins and uses thereof |
| 08/29/2007 | EP1824472A1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 08/29/2007 | EP1425019B1 Pharmaceutical composition comprising an androgen |
| 08/29/2007 | EP1404652B1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7261893 Neutralizing antibodies against GDF-8 and uses therefor |
| 08/23/2007 | WO2007094404A1 Process for production of optically active carboxylic acid compound |
| 08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 08/23/2007 | WO2007071839A3 Potentiation of apoptosis by monoclonal antibodies |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | CA2645734A1 Method of treating inflammatory diseases |
| 08/23/2007 | CA2560107A1 Nutritional composition and method for increasing creatine uptake and retention in skeletal muscle, increasing muscle mass and strength, increasing exercise capacity and for aiding recovery following exercise |
| 08/22/2007 | EP1820854A2 JNK3 modulators and methods of use |
| 08/22/2007 | EP1610785B1 Pharmaceutical combination for the treatment of spasticity and/or pain |
| 08/22/2007 | EP1499334B1 Petasin-free polar petasites extract fractions and their use to treat pain |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2007 | CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
| 08/22/2007 | CN1332669C Dripping pills for reducing swelling and easing pain and its preparing method |
| 08/22/2007 | CN101020659A 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application |
| 08/22/2007 | CN101019814A Application of non-depolarizing muscular relaxant in preventing and eliminating facial wrinkles |
| 08/21/2007 | US7259179 Kinase inhibitors |
| 08/21/2007 | US7259168 2-Aminoalkyl-thieno[2,3-d]pyrimidines |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007091107A1 Treatment of duchenne muscular dystrophy |
| 08/16/2007 | WO2007091106A2 Treatment of duchenne muscular dystrophy |
| 08/16/2007 | WO2007047112A3 Anti-myostatin antibodies |
| 08/16/2007 | WO2007044411A3 Anti-myostatin antibodies |
| 08/16/2007 | WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 08/16/2007 | US20070191478 Methods of treating cardio pulmonary diseases with NO group compounds |
| 08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
| 08/16/2007 | US20070191274 Active hedgehog protein conjugate |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | CA2641884A1 Treatment of duchenne muscular dystrophy |
| 08/15/2007 | EP1496904B1 Use of pharmaceuticals containing n, n'-disubstituted piperazine compounds |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1377590B1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3cr1 receptor |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1272614B1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/15/2007 | EP1254251B1 Neurosteroids as markers for alzheimer's disease |
| 08/15/2007 | CN1331865C Polymorphs and compositions and methods related thereto |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331532C Botulinum toxin pharmaceutical compositions |
| 08/15/2007 | CN101018565A Methods for treating conditions associated with MASP-2 dependent complement activation |
| 08/14/2007 | US7256217 Prodrugs of excitatory amino acids |
| 08/14/2007 | US7256216 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/14/2007 | CA2370030C Sodium channel blocker compositions and the use thereof |
| 08/14/2007 | CA2173504C Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |